Interstitial lung disease and Atelectasis

Summary:

Atelectasis is found among people with Interstitial lung disease, especially for people who are male, 2-9 old.

The study analyzes which people have Atelectasis with Interstitial lung disease. It is created by eHealthMe based on reports of 81 people who have Interstitial lung disease from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Interstitial lung disease?

Interstitial lung disease is found to be associated with 1,499 drugs and 1,839 conditions by eHealthMe. Check the latest studies of Interstitial lung disease.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,446 drugs and 1,636 conditions by eHealthMe. Check the latest studies of Atelectasis.



On Jul, 19, 2026

81 people who have Interstitial Lung Disease and Atelectasis are studied.

Would you have Atelectasis when you have Interstitial lung disease?

Gender of people who have Interstitial Lung Disease and experienced Atelectasis *:

  • female: 3.95 %
  • male: 96.05 %

Age of people who have Interstitial Lung Disease and experienced Atelectasis *:

  • 0-1: 6.25 %
  • 2-9: 90.62 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 3.12 %

Common co-existing conditions for these people *:

  1. Pneumonia: 71 people, 87.65%
  2. Breathing - Slowed Or Stopped: 71 people, 87.65%
  3. Nausea And Vomiting: 71 people, 87.65%
  4. Pneumococcal Sepsis (pneumococcal sepsis is a serious medical condition where bacteria, specifically streptococcus pneumoniae): 70 people, 86.42%
  5. Pneumococcal Infection (infection caused by streptococcus pneumoniae): 27 people, 33.33%
  6. Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 21 people, 25.93%
  7. Head Injury: 21 people, 25.93%
  8. Intestinal Ischaemia (decreased supply of oxygenated blood to the intestines): 21 people, 25.93%
  9. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 20 people, 24.69%
  10. Circulatory Collapse: 20 people, 24.69%

Common drugs taken by these people *:

  1. Pulmozyme: 62 people, 76.54%
  2. Piperacillin And Tazobactam: 46 people, 56.79%
  3. Ventolin: 38 people, 46.91%
  4. Ciprofloxacin: 37 people, 45.68%
  5. Propofol: 36 people, 44.44%
  6. Meropenem: 36 people, 44.44%
  7. Fentanyl: 35 people, 43.21%
  8. Albuterol: 32 people, 39.51%
  9. Gentamicin: 32 people, 39.51%
  10. Sodium Chloride: 30 people, 37.04%

Common symptoms for these people *:

  1. Diarrhea: 72 people, 88.89%
  2. Pneumonia: 72 people, 88.89%
  3. Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 71 people, 87.65%
  4. Breathing - Slowed Or Stopped: 71 people, 87.65%
  5. Chest X-Ray Abnormal: 71 people, 87.65%
  6. Circulatory Collapse: 71 people, 87.65%
  7. Sputum Increased: 71 people, 87.65%
  8. Dehydration (dryness resulting from the removal of water): 71 people, 87.65%
  9. Weakness: 70 people, 86.42%
  10. Dyspnea (difficult or laboured breathing): 70 people, 86.42%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Atelectasis:

All the conditions that are associated with Atelectasis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atelectasis and Interstitial lung disease, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: